Orsini, a US-based provider of rare disease pharmacy solutions, has launched ORBIT Track, a next-generation portal designed to enhance collaboration with biopharma partners.
The platform offers real-time visibility into patient case information to improve care for patients with rare and complex conditions by streamlining communication and data sharing.
Building on the success of the 2024 launch of ORBIT (Orsini Rare Business Intelligence Technology), ORBIT Track strengthens Orsini’s data-first ecosystem.
The platform is designed to improve outcomes for both rare disease patients and partners.
Key features of ORBIT Track include real-time case visibility, enabling faster patient access to treatment through up-to-date case progress and milestones.
The platform also offers smart collaboration tools, allowing secure HIPAA-compliant messaging for streamlined communication between biopharma partners and Orsini.
Users can access actionable case insights, including patient progress updates, benefits information, and medical documentation, all in one centralised location.
ORBIT Track ensures next-level data security with role-based access and PHI masking capabilities.
The platform is web-based and device-agnostic, providing seamless performance across smartphones, tablets, and desktops, ensuring users can access crucial information anytime, anywhere.
Orsini chief information officer Ashok Singh said: “We built ORBIT Track to speed up critical decisions, while maintaining the highest standards of security and compliance.
“We are continuously working to advance rare disease care, and with this launch we have strengthened our ability to support patients and empower our partners through innovative technology.”
Established in 1987, Orsini has been providing comprehensive care for rare diseases and gene therapies to simplify patient access to advanced therapies.
The company collaborates with biopharma innovators, healthcare providers, and payors to support patients and their families in accessing groundbreaking treatments.
Orsini’s integrated rare disease pharmacy solutions include pharmacy distribution, patient services, clinical management, and convenient home infusion services.
